Athos Therapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$10.3M
- Investors
-
1
Athos Therapeutics General Information
Description
Developer of an artificial intelligence technology platform and therapeutics designed for patients with inflammatory bowel and autoimmune diseases. The company's platform offers drug discovery and development services that use machine learning algorithms that identify novel and safe drug or gene targets for individual patients based on the integration of medicinal chemistry and systems biology, enabling medical professionals to identify the compounds that safely and efficiently target key disease factors.
Contact Information
Website
www.athostx.comCorporate Office
- 11301 West Olympic Boulevard
- Suite 592
- Los Angeles, CA 90064
- United States
Corporate Office
- 11301 West Olympic Boulevard
- Suite 592
- Los Angeles, CA 90064
- United States
Athos Therapeutics Timeline
Athos Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 14-May-2026 | $10.3M | Completed | Clinical Trials - Phase 1 | ||
| 3. Later Stage VC (Series B) | 16-Feb-2024 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC (Series A) | 16-Nov-2021 | $20.4M | $24.7M | Completed | Pre-Clinical Trials | |
| 1. Early Stage VC (Series A) | 01-Mar-2020 | $4.25M | $4.25M | Completed | Startup |
Athos Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Athos Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Athos Therapeutics Patents
Athos Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12387013-B1 | Data integration and quality control system | Active | 30-Dec-2024 | ||
| US-20260187286-A1 | Data integration and quality control system | Pending | 30-Dec-2024 | ||
| WO-2026147634-A1 | Omics data integration and quality control system | Pending | 30-Dec-2024 | ||
| AU-2024306046-A1 | Small molecules for the treatment of autoimmune disorders | Pending | 26-Jun-2023 | ||
| EP-4731629-A1 | Small molecules for the treatment of autoimmune disorders | Pending | 26-Jun-2023 | A61P29/00 |
Athos Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Athos Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| JDY Capital | Family Office | Minority |
Athos Therapeutics FAQs
-
When was Athos Therapeutics founded?
Athos Therapeutics was founded in 2019.
-
Where is Athos Therapeutics headquartered?
Athos Therapeutics is headquartered in Los Angeles, CA.
-
What is the size of Athos Therapeutics?
Athos Therapeutics has 37 total employees.
-
What industry is Athos Therapeutics in?
Athos Therapeutics’s primary industry is Drug Discovery.
-
Is Athos Therapeutics a private or public company?
Athos Therapeutics is a Private company.
-
What is Athos Therapeutics’s current revenue?
The current revenue for Athos Therapeutics is .
-
How much funding has Athos Therapeutics raised over time?
Athos Therapeutics has raised $69.9M.
-
Who are Athos Therapeutics’s investors?
JDY Capital has invested in Athos Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
